Refractory Celiac Disease

Georgia Malamut, Joseph A Murray, Christophe Cellier

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

A small subset of patients with celiac disease become refractory to a gluten-free diet, with persistent or recurrent symptoms of malabsorption and intestinal villous atrophy. This condition, defined as refractory celiac disease (RCD), is diagnosed after other small bowel diseases with villous atrophy are excluded. RCD is subdivided into 2 subgroups: type I RCD and type II RCD (RCDII). This latter condition is considered a low-grade intraepithelial lymphoma and has a poor prognosis. This article reviews the clinical and pathologic features of RCD and recent pathogenic findings in RCDII, offering a model to study how inflammation can drive T-cell lymphomagenesis.

Original languageEnglish (US)
Pages (from-to)759-772
Number of pages14
JournalGastrointestinal Endoscopy Clinics of North America
Volume22
Issue number4
DOIs
StatePublished - Oct 2012

Fingerprint

Celiac Disease
Atrophy
Gluten-Free Diet
Non-Hodgkin's Lymphoma
Inflammation
T-Lymphocytes

Keywords

  • Aberrant intraepithelial lymphocytes
  • Immunosuppressive treatments
  • Refractory celiac disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Refractory Celiac Disease. / Malamut, Georgia; Murray, Joseph A; Cellier, Christophe.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 22, No. 4, 10.2012, p. 759-772.

Research output: Contribution to journalReview article

Malamut, Georgia ; Murray, Joseph A ; Cellier, Christophe. / Refractory Celiac Disease. In: Gastrointestinal Endoscopy Clinics of North America. 2012 ; Vol. 22, No. 4. pp. 759-772.
@article{26c556c6f0074ac2a11178cde60248f6,
title = "Refractory Celiac Disease",
abstract = "A small subset of patients with celiac disease become refractory to a gluten-free diet, with persistent or recurrent symptoms of malabsorption and intestinal villous atrophy. This condition, defined as refractory celiac disease (RCD), is diagnosed after other small bowel diseases with villous atrophy are excluded. RCD is subdivided into 2 subgroups: type I RCD and type II RCD (RCDII). This latter condition is considered a low-grade intraepithelial lymphoma and has a poor prognosis. This article reviews the clinical and pathologic features of RCD and recent pathogenic findings in RCDII, offering a model to study how inflammation can drive T-cell lymphomagenesis.",
keywords = "Aberrant intraepithelial lymphocytes, Immunosuppressive treatments, Refractory celiac disease",
author = "Georgia Malamut and Murray, {Joseph A} and Christophe Cellier",
year = "2012",
month = "10",
doi = "10.1016/j.giec.2012.07.007",
language = "English (US)",
volume = "22",
pages = "759--772",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Refractory Celiac Disease

AU - Malamut, Georgia

AU - Murray, Joseph A

AU - Cellier, Christophe

PY - 2012/10

Y1 - 2012/10

N2 - A small subset of patients with celiac disease become refractory to a gluten-free diet, with persistent or recurrent symptoms of malabsorption and intestinal villous atrophy. This condition, defined as refractory celiac disease (RCD), is diagnosed after other small bowel diseases with villous atrophy are excluded. RCD is subdivided into 2 subgroups: type I RCD and type II RCD (RCDII). This latter condition is considered a low-grade intraepithelial lymphoma and has a poor prognosis. This article reviews the clinical and pathologic features of RCD and recent pathogenic findings in RCDII, offering a model to study how inflammation can drive T-cell lymphomagenesis.

AB - A small subset of patients with celiac disease become refractory to a gluten-free diet, with persistent or recurrent symptoms of malabsorption and intestinal villous atrophy. This condition, defined as refractory celiac disease (RCD), is diagnosed after other small bowel diseases with villous atrophy are excluded. RCD is subdivided into 2 subgroups: type I RCD and type II RCD (RCDII). This latter condition is considered a low-grade intraepithelial lymphoma and has a poor prognosis. This article reviews the clinical and pathologic features of RCD and recent pathogenic findings in RCDII, offering a model to study how inflammation can drive T-cell lymphomagenesis.

KW - Aberrant intraepithelial lymphocytes

KW - Immunosuppressive treatments

KW - Refractory celiac disease

UR - http://www.scopus.com/inward/record.url?scp=84867686509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867686509&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2012.07.007

DO - 10.1016/j.giec.2012.07.007

M3 - Review article

C2 - 23083992

AN - SCOPUS:84867686509

VL - 22

SP - 759

EP - 772

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 4

ER -